HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board
Feb 16, 2016 21:01 pm UTC| Business
TUCSON, Ariz., Feb. 16, 2016 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the establishment of a Scientific Advisory...
Cytokinetics, Inc. Reports Fourth Quarter 2015 Financial Results
Feb 16, 2016 21:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 16, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) reported total research and development revenuesfor the fourth quarter of 2015 were $9.8 million, compared to $21.8 million, which included...
T2 Biosystems Reports 2015 Fourth Quarter, Full Year Results
Feb 16, 2016 21:00 pm UTC| Business
LEXINGTON, Mass., Feb. 16, 2016 -- T2 Biosystems, Inc. (NASDAQ:TTOO) today reported operating highlights and financial results for the fourth quarter and year ended December 31, 2015. Recent operational highlights...
Chart Industries Announces Fourth Quarter and Year 2015 Conference Call
Feb 16, 2016 21:00 pm UTC| Business
CLEVELAND, Feb. 16, 2016 -- Chart Industries, Inc. (NASDAQ:GTLS) has scheduled a conference call for Thursday, February 25, 2016, at 10:30 a.m. ET to discuss its fourth quarter, full year 2015 financial results and...
CB Financial Services, Inc. Announces Annual Meeting Date
Feb 16, 2016 21:00 pm UTC| Business
CARMICHAELS, Pa., Feb. 16, 2016 -- CB Financial Services, Inc. (NASDAQ:CBFV), the holding company of Community Bank, today announced that the annual meeting of stockholders will be held on Wednesday, May 18, 2016 at...
Nanophase Technologies Announces Year End 2015 Financial Conference Call
Feb 16, 2016 21:00 pm UTC| Business
ROMEOVILLE, Ill., Feb. 16, 2016 -- Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today announced the Company will disseminate a financial...
Endocyte to Present at Upcoming Conferences
Feb 16, 2016 21:00 pm UTC| Business
WEST LAFAYETTE, Ind., Feb. 16, 2016 -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the...